Combined imaging pinpoints those who would benefit from ICDs

08/12/2010 |

A Japanese study published in this month's Journal of Nuclear Medicine showed that using cardiac sympathetic nerve imaging with 123I-metaiodobenzylguanidine in combination with myocardial perfusion imaging helped determine which patients would need the implantation of a cardioverter defibrillator to deliver internal shocks. While there are still issues to be addressed in the study, the findings present "a rationale for further studies investigating the role of nuclear imaging for better selection of ICD candidates beyond left ventricular ejection measurements," the researchers said.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA